Discover the significance of the EBITDA/EV multiple, a key financial ratio for ROI, how it compares to EV/EBITDA, and its impact on evaluating company performance.

LIANYUNGANG, JIANGSU, CHINA, March 4, 2026 /EINPresswire.com/ -- I. Introduction: China’s Integrated Solution in the ...

Background Ocular chronic graft versus host disease (oGVHD) seriously affects ocular surface, which often results in corneal ...

Plan your Fetch Charlotte schedule with these lectures to watch. The dvm360 team is heading to Charlotte, North Carolina! From March 13-14, 2026, dvm360’s team—our amazing faculty, exhibitors, and ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

As the population ages, China will face an ever-increasing burden from CS. Strategies targeting elder population and high-risk groups should be prioritized in the establishment of management related ...

Sedentary behaviour (SB) is linked to a higher risk of metabolic disorders, cardiovascular disease, all-cause mortality and musculoskeletal decline. Office workers (OW) are particularly vulnerable to ...

The arrival of such advanced diagnostic technology is timely for India, which is currently facing what experts describe as a 'cardiovascular epidemic' ...

Background Metabolic dysfunction associated steatotic liver disease (MASLD), the most common chronic liver disease globally, may originate early in life. While maternal obesity is linked to offspring ...

Nissan comes by its inventiveness naturally, as one of the oldest carmakers in Japan. Though the company was officially ...

Looking through the atmosphere is like looking through a piece of old stained glass. The glass has defects that distort the image. The atmosphere also has defects that distort the image, but the ...

Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...